Evidence map›Paper›PMID 32250460›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2020

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Stella M Papa, Patrik Brundin, Victor S C Fung, Un Jung Kang, David J Burn, Carlo Colosimo, Han-Lin Chiang, Roy N Alcalay, Claudia Trenkwalder, MDS-Scientific Issues Committee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Incidence and Mortality Ratio of Ischemic Cerebrovascular Accidents in COVID-19 Cases: A Systematic Review and Meta-Analysis.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 2021
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Article
  19. Review
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stella M PapaYerkes National Primate Research Center, Department of Neurology, Emory University School of Medicine, Atlanta, Georgia, USA.
Patrik BrundinVan Andel Institute, Center for Neurodegenerative Science, Grand Rapids, Michigan, USA.
Victor S C FungMovement Disorders Unit, Department of Neurology, Westmead Hospital and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Un Jung KangDepartment of Neurology, New York University Grossman School of Medicine, New York, New York, USA.ORCID 0000-0002-5970-6839
David J BurnDepartment of Medical Sciences, Newcastle University Medical School, Newcastle, United Kingdom.
Carlo ColosimoDepartment of Neurology, Santa Maria University Hospital, Terni, Italy.
Han-Lin ChiangDepartment of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
Roy N AlcalayDepartment of Neurology, Columbia University Irving Medical Center, New York, New York, USA.
Claudia TrenkwalderParacelsus-Elena Klinik, Kassel, Department of Neurosurgery, University Medical Center, Goettingen, Goettingen, Germany.
MDS-Scientific Issues Committee

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI JOHNS, MICHAEL M · 1985 to 2011
$114.0M
Regulation of Motor Function in Parkinson's DiseaseR01NS045962 · NINDS · EMORY UNIVERSITY · PI PAPA, STELLA M, TRAYNELIS, STEPHEN F · 2004 to 2022
$5.2M
Manipulating Gene Expression in the Dyskinesias of Parkinson's DiseaseR01NS073994 · NINDS · EMORY UNIVERSITY · PI MOURADIAN, M. MARAL, PAPA, STELLA M · 2011 to 2016
$2.4M
A novel gene therapy for motor symptoms of Parkinson's diseaseR21NS110416 · NINDS · EMORY UNIVERSITY · PI PAPA, STELLA M · 2019 to 2019
$483k
NCRR NIH HHS P51 RR000165NIH HHS P51 OD011132NINDS NIH HHS R01 NS045962NINDS NIH HHS R01 NS073994NINDS NIH HHS R21 NS110416
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Movement DisordersParkinson DiseaseBetacoronavirusClinical Trials as TopicCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralSARS-CoV-2Telemedicine

Identifiers

PMID32250460
PMCPMC7996401

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.